185 related articles for article (PubMed ID: 9754277)
1. [Anti-HCV serology for screening, diagnosis and surveillance of hepatitis C: role of the immunoblot].
Dubois F; Barin F; Goudeau A
Ann Biol Clin (Paris); 1998; 56(4):417-26. PubMed ID: 9754277
[TBL] [Abstract][Full Text] [Related]
2. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
[TBL] [Abstract][Full Text] [Related]
3. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibodies to hepatitis C virus in transfused children with cancer.
Monteleone PM; Andrzejewski C; Kelleher JF
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):309-13. PubMed ID: 7978047
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ
J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
[TBL] [Abstract][Full Text] [Related]
7. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
[TBL] [Abstract][Full Text] [Related]
8. Limits of diagnostic accuracy of anti-hepatitis C virus antibodies detection by ELISA and immunoblot assay.
Suslov AP; Kuzin SN; Golosova TV; Shalunova NV; Malyshev NA; Sadikova NV; Vavilova LM; Somova AV; Musina EE; Ivanova MV; Kipor TT; Timonin IM; Kuzina LE; Godkov MA; Bajenov AI; Nesterenko VG
Russ J Immunol; 2002 Jul; 7(2):175-84. PubMed ID: 12687261
[TBL] [Abstract][Full Text] [Related]
9. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
Myrmel H; Navaratnam V; Asjø B
J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611
[TBL] [Abstract][Full Text] [Related]
10. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta.
Meky FA; Stoszek SK; Abdel-Hamid M; Selim S; Abdel-Wahab A; Mikhail N; El-Kafrawy S; El-Daly M; Abdel-Aziz F; Sharaf S; Mohamed MK; Engle RE; Emerson SU; Purcell RH; Fix AD; Strickland GT
Clin Infect Dis; 2006 Mar; 42(5):628-33. PubMed ID: 16447107
[TBL] [Abstract][Full Text] [Related]
11. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
Espinosa M; Martin-Malo A; Alvarez de Lara MA; Soriano S; Aljama P
Clin Nephrol; 2000 Aug; 54(2):151-6. PubMed ID: 10968693
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic tests for hepatitis C.
Gretch DR
Hepatology; 1997 Sep; 26(3 Suppl 1):43S-47S. PubMed ID: 9305663
[TBL] [Abstract][Full Text] [Related]
13. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
[TBL] [Abstract][Full Text] [Related]
16. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the patients with low levels of anti-HCV positivity].
Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M
Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of hepatitis C.
Lok AS; Gunaratnam NT
Hepatology; 1997 Sep; 26(3 Suppl 1):48S-56S. PubMed ID: 9305664
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection.
Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of third-generation screening and confirmatory assays for HCV antibodies.
Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C
Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
